Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Lars Eilertsen
Introduction
Lars Eilertsen is a notable inventor based in Søborg, Denmark, recognized for his significant contributions to the field of drug delivery technology. With a total of 12 patents to his name, Eilertsen has made strides in developing devices that enhance the efficiency and effectiveness of drug administration.
Latest Patents
Among his latest innovations is a drug delivery device designed to streamline the process of administering medication. This device features a housing with an opening and a drug storage container that includes a delivery member. The insertion end of the delivery member is configured to extend partially through the opening during a delivery state. Additionally, the device incorporates a guard that is moveably positioned adjacent to the opening and a plunger with a cylindrical body portion. The plunger is designed to move toward the distal end of the container to expel the drug through the delivery member. Furthermore, the device includes a plunger biasing member that urges the plunger toward the distal end and a releaser member that defines a guide for the flange, along with an indicator that generates an audible signal to indicate the end of drug delivery.
Career Highlights
Lars Eilertsen is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to healthcare. His work at Amgen has allowed him to focus on developing advanced drug delivery systems that improve patient outcomes.
Collaborations
Eilertsen has collaborated with talented colleagues, including Austin Davis and Gregory Thomas Nowak, to further enhance the capabilities of drug delivery technologies. Their combined expertise has contributed to the successful development of groundbreaking inventions.
Conclusion
Lars Eilertsen's work in the field of drug delivery devices exemplifies the impact of innovation on healthcare. His patents reflect a commitment to improving the way medications are administered, ultimately benefiting patients worldwide.